{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:05:02Z","timestamp":1790701502855,"version":"4.1.0"},"reference-count":53,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Commission of Jiangsu Province","award":["MQ2024047"],"award-info":[{"award-number":["MQ2024047"]}]},{"name":"Nantong Municipal Health Commission","award":["QN2024035"],"award-info":[{"award-number":["QN2024035"]}],"id":[{"id":"https:\/\/ror.org\/0578pqz98","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Nantong Municipal Health Commission","award":["QN2024036"],"award-info":[{"award-number":["QN2024036"]}],"id":[{"id":"https:\/\/ror.org\/0578pqz98","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Nantong Municipal Health Commission","award":["QN2024038"],"award-info":[{"award-number":["QN2024038"]}],"id":[{"id":"https:\/\/ror.org\/0578pqz98","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Nantong Science and Technology Bureau","award":["JC2023108"],"award-info":[{"award-number":["JC2023108"]}],"id":[{"id":"https:\/\/ror.org\/02tx34m84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Nantong Science and Technology Bureau","award":["JC2025001"],"award-info":[{"award-number":["JC2025001"]}],"id":[{"id":"https:\/\/ror.org\/02tx34m84","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Nantong University Clinical Medicine Specialized Research Fund","award":["2024LZ015"],"award-info":[{"award-number":["2024LZ015"]}],"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Nantong University Clinical Medicine Specialized Research Fund","award":["2024JQ038"],"award-info":[{"award-number":["2024JQ038"]}],"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Nantong Infectious Diseases Alliance","award":["NTCRB2025006"],"award-info":[{"award-number":["NTCRB2025006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Enhancer RNAs (eRNAs) are important regulators of tumor development and progression. Nevertheless, the diagnostic utility of circulating eRNAs in hepatocellular carcinoma (HCC) remains unclear. Methods: This was a retrospective study. The recently identified eRNA, leucine-rich repeat-containing 3 divergent transcript (LRRC3-DT), was analyzed in serum samples, tissue specimens, and various cell lines. Its diagnostic performance was evaluated alone and in combination with alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) using receiver operating characteristic (ROC) curve analysis. Functional investigations were performed to assess the biological role of LRRC3-DT by overexpressing and knocking down this eRNA in HCC cell lines. Furthermore, using transcriptome sequencing, potential target genes of LRRC3-DT were identified. Results: The serum levels of LRRC3-DT were significantly lower in patients diagnosed with HCC than in healthy controls. When LRRC3-DT was assessed alongside AFP and PIVKA-II, the combination improved sensitivity for the detection of HCC. Despite earlier research indicating that LRRC3-DT is present primarily in the nucleus and is strongly associated with tumor proliferation, invasion, and apoptosis, the serum levels of LRRC3-DT were similar between patients with HCC and those with benign liver diseases in the present study. These findings indicate limited specificity in distinguishing between these two conditions. Conclusions: Serum LRRC3-DT represents a potential auxiliary biomarker for early HCC screening; its combined use with other indicators improved diagnostic performance. However, it cannot individually discriminate HCC from benign liver disorders, and additional validation studies are warranted to confirm its differential diagnostic value.<\/jats:p>","DOI":"10.31083\/fbl54580","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:21:51Z","timestamp":1790698911000},"source":"Crossref","is-referenced-by-count":0,"title":["LRRC3-DT Inhibits Malignant Behaviors of Hepatocellular Carcinoma and is Associated With CCDC81 Expression"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6109-5096","authenticated-orcid":true,"given":"Jinglu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Liver Disease Research Institute, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-177X","authenticated-orcid":true,"given":"Yunfeng","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1437-3206","authenticated-orcid":true,"given":"Mei","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Liver Disease Research Institute, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0837-7414","authenticated-orcid":true,"given":"Zhiqiang","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4378-3676","authenticated-orcid":true,"given":"Liuxia","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Liver Disease Research Institute, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3602-4958","authenticated-orcid":true,"given":"Huixuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Liver Disease Research Institute, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1108-4735","authenticated-orcid":true,"given":"Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Liver Disease Research Institute, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-0533","authenticated-orcid":true,"given":"Linling","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Liver Disease Research Institute, Af\ufb01liated Nantong Hospital 3 of Nantong University, Nantong Third People\u2019s Hospital, Nantong University, 226000 Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Reviews. 2023; 42: 629\u2013652.","DOI":"10.1007\/s10555-023-10084-4"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW, et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nature Cancer. 2022; 3: 386\u2013401.","DOI":"10.1038\/s43018-022-00357-2"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Martinino A, Bucaro A, Cardella F, Wazir I, Frongillo F, Ardito F, et al. Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses. Frontiers in Oncology. 2024; 14: 1366607.","DOI":"10.3389\/fonc.2024.1366607"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Lee KK, Kim DG, Moon IS, Lee MD, Park JH. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. Journal of Surgical Oncology. 2010; 101: 47\u201353.","DOI":"10.1002\/jso.21415"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Annals of Surgery. 2015; 261: 947\u2013955.","DOI":"10.1097\/SLA.0000000000000710"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, et al. Advances in postoperative adjuvant therapy for primary liver cancer. World Journal of Gastrointestinal Oncology. 2022; 14: 1604\u20131621.","DOI":"10.4251\/wjgo.v14.i9.1604"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rajendran L, Ivanics T, Claasen MP, Muaddi H, Sapisochin G. The management of post-transplantation recurrence of hepatocellular carcinoma. Clinical and Molecular Hepatology. 2022; 28: 1\u201316.","DOI":"10.3350\/cmh.2021.0217"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Thorgeirsson SS, Lee JS, Grisham JW. Functional genomics of hepatocellular carcinoma. Hepatology (Baltimore, Md.). 2006; 43: S145\u201350.","DOI":"10.1002\/hep.21063"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Senapedis W, Gallagher KM, Figueroa E, Farelli JD, Lyng R, Hodgson JG, et al. Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models. Nature Communications. 2024; 15: 7875.","DOI":"10.1038\/s41467-024-52202-y"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Yang C, Huang X, Liu Z, Qin W, Wang C. Metabolism-associated molecular classification of hepatocellular carcinoma. Molecular Oncology. 2020; 14: 896\u2013913.","DOI":"10.1002\/1878-0261.12639"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Ding Y, Liu K, Xu Y, Zhao Q, Lou S, Xiang X, et al. Combination of inflammatory score\/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Cancer Medicine. 2020; 9: 3057\u20133069.","DOI":"10.1002\/cam4.2968"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Sauzay C, Petit A, Bourgeois AM, Barbare JC, Chauffert B, Galmiche A, et al. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2016; 463: 39\u201344.","DOI":"10.1016\/j.cca.2016.10.006"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kudo M. Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma. Liver Cancer. 2024; 13: 113\u2013118.","DOI":"10.1159\/000537897"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kim DY, Toan BN, Tan CK, Hasan I, Setiawan L, Yu ML, et al. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clinical and Molecular Hepatology. 2023; 29: 277\u2013292.","DOI":"10.3350\/cmh.2022.0212"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Furlong EEM, Levine M. Developmental enhancers and chromosome topology. Science (New York, N.Y.). 2018; 361: 1341\u20131345.","DOI":"10.1126\/science.aau0320"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Chen H, Levo M, Barinov L, Fujioka M, Jaynes JB, Gregor T. Dynamic interplay between enhancer-promoter topology and gene activity. Nature Genetics. 2018; 50: 1296\u20131303.","DOI":"10.1038\/s41588-018-0175-z"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Liu F. Enhancer-derived RNA: A Primer. Genomics, Proteomics & Bioinformatics. 2017; 15: 196\u2013200.","DOI":"10.1016\/j.gpb.2016.12.006"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010; 465: 182\u2013187.","DOI":"10.1038\/nature09033"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Cai YM, Lu ZQ, Li B, Huang JY, Zhang M, Chen C, et al. Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers. Military Medical Research. 2024; 11: 36.","DOI":"10.1186\/s40779-024-00539-2"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Chen W, Wang Z, Wang Y, Lin J, Chen S, Chen H, et al. Enhancer RNA Transcriptome-Wide Association Study Reveals a Distinctive Class of Pan-Cancer Susceptibility eRNAs. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2025; 12: e2411974.","DOI":"10.1002\/advs.202411974"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"You Z, Liu C, Wang C, Ling Z, Wang Y, Wang Y, et al. LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P. Molecular Cancer Therapeutics. 2019; 18: 2469\u20132479.","DOI":"10.1158\/1535-7163.MCT-19-0095"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Li R, Zhao H, Huang X, Zhang J, Bai R, Zhuang L, et al. Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. Nature Genetics. 2023; 55: 2224\u20132234.","DOI":"10.1038\/s41588-023-01568-8"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Chen W, Wu C, Li Y, Wang T, Huang M, Wang M, et al. Mir-483-5p-mediated activating of IGF2\/H19 enhancer up-regulates IGF2\/H19 expression via chromatin loops to promote the malignant progression of hepatocellular carcinoma. Molecular Cancer. 2025; 24: 10.","DOI":"10.1186\/s12943-024-02204-7"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Cheng M, Wang B, Duan L, Jin Y, Zhang W, Li N. HOTAIR Knockdown Increases the Sensitivity of Hepatocellular Carcinoma Cells to Sorafenib by Disrupting miR-145-5p\/HK2 Axis-Mediated Mitochondrial Function and Glycolysis. Frontiers in Bioscience (Landmark edition). 2025; 30: 37368.","DOI":"10.31083\/FBL37368"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Ismail M, Fadul MM, Taha R, Siddig O, Elhafiz M, Yousef BA, et al. Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects. Hepatology International. 2024; 18: 1715\u20131730.","DOI":"10.1007\/s12072-024-10722-1"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Sasaki R, Kanda T, Yokosuka O, Kato N, Matsuoka S, Moriyama M. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside. International Journal of Molecular Sciences. 2019; 20: 1406.","DOI":"10.3390\/ijms20061406"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Villarroya-Beltri C, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Cabo F, P\u00e9rez-Hern\u00e1ndez D, V\u00e1zquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nature Communications. 2013; 4: 2980.","DOI":"10.1038\/ncomms3980"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Peng X, Li X, Yang S, Huang M, Wei S, Ma Y, et al. LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation. Journal of Experimental & Clinical Cancer Research : CR. 2021; 40: 183.","DOI":"10.1186\/s13046-021-01990-y"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Zhou C, York SR, Chen JY, Pondick JV, Motola DL, Chung RT, et al. Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins. Genome Medicine. 2016; 8: 31.","DOI":"10.1186\/s13073-016-0285-0"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JC, et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology. 2018; 69: 182\u2013236.","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Yilma M, Saxena V, Mehta N. Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis. Current Gastroenterology Reports. 2022; 24: 1\u20139.","DOI":"10.1007\/s11894-022-00835-8"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Billi M, De Marinis E, Gentile M, Nervi C, Grignani F. Nuclear miRNAs: Gene Regulation Activities. International Journal of Molecular Sciences. 2024; 25: 6066.","DOI":"10.3390\/ijms25116066"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Chen S, Wang Y, Li D, Wang H, Zhao X, Yang J, et al. Mechanisms Controlling MicroRNA Expression in Tumor. Cells. 2022; 11: 2852.","DOI":"10.3390\/cells11182852"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Zhang Y. LncRNA-encoded peptides in cancer. Journal of Hematology & Oncology. 2024; 17: 66.","DOI":"10.1186\/s13045-024-01591-0"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Song G, Yu X, Shi H, Sun B, Amateau S. miRNAs in HCC, pathogenesis, and targets. Hepatology (Baltimore, Md.). 2024;  https:\/\/doi.org\/10.1097\/HEP.0000000000001177","DOI":"10.1097\/HEP.0000000000001177"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Tian Y, Zhang M, Liu LX, Wang ZC, Liu B, Huang Y, et al. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis. Frontiers in Immunology. 2024; 15: 1400744.","DOI":"10.3389\/fimmu.2024.1400744"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Klingenberg M, Matsuda A, Diederichs S, Patel T. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. Journal of Hepatology. 2017; 67: 603\u2013618.","DOI":"10.1016\/j.jhep.2017.04.009"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Saadh MJ, Hussain QM, Alazzawi TS, Fahdil AA, Athab ZH, Yarmukhamedov B, et al. MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis. Biochemical Genetics. 2025; 63: 1014\u20131062.","DOI":"10.1007\/s10528-024-10897-0"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Kristj\u00e1nsd\u00f3ttir K, Dziubek A, Kang HM, Kwak H. Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture. Nature Communications. 2020; 11: 5963.","DOI":"10.1038\/s41467-020-19829-z"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Zhang Z, Lee JH, Ruan H, Ye Y, Krakowiak J, Hu Q, et al. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. Nature Communications. 2019; 10: 4562.","DOI":"10.1038\/s41467-019-12543-5"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Sartorelli V, Lauberth SM. Enhancer RNAs are an important regulatory layer of the epigenome. Nature Structural & Molecular Biology. 2020; 27: 521\u2013528.","DOI":"10.1038\/s41594-020-0446-0"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Hou TY, Kraus WL. Spirits in the Material World: Enhancer RNAs in Transcriptional Regulation. Trends in Biochemical Sciences. 2021; 46: 138\u2013153.","DOI":"10.1016\/j.tibs.2020.08.007"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Zhao Y, Wang L, Ren S, Wang L, Blackburn PR, McNulty MS, et al. Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer. Cell Reports. 2016; 15: 599\u2013610.","DOI":"10.1016\/j.celrep.2016.03.038"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Li C, Yang J, Liu C, Wang X, Zhang L. Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment. Pharmacological Research. 2020; 158: 104848.","DOI":"10.1016\/j.phrs.2020.104848"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Xie C, Li SY, Fang JH, Zhu Y, Yang JE. Functional long non-coding RNAs in hepatocellular carcinoma. Cancer Letters. 2021; 500: 281\u2013291.","DOI":"10.1016\/j.canlet.2020.10.042"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology (Baltimore, Md.). 2011; 54: 1679\u20131689.","DOI":"10.1002\/hep.24563"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Cui M, Xiao Z, Wang Y, Zheng M, Song T, Cai X, et al. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway. Cancer Research. 2015; 75: 846\u2013857.","DOI":"10.1158\/0008-5472.CAN-14-1192"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Wu L, Yang Z, Zhang J, Xie H, Zhou L, Zheng S. Long noncoding RNA HOTTIP expression predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Hepatobiliary Surgery and Nutrition. 2018; 7: 429\u2013439.","DOI":"10.21037\/hbsn.2018.10.07"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Liu Z, Yan W, Liu S, Liu Z, Xu P, Fang W. Regulatory network and targeted interventions for CCDC family in tumor pathogenesis. Cancer Letters. 2023; 565: 216225.","DOI":"10.1016\/j.canlet.2023.216225"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Liu X, Liu F, Nai S. Centrosome Protein CCDC81 Promotes Ciliogenesis. Cytoskeleton (Hoboken, N.J.). 2025;  https:\/\/doi.org\/10.1002\/cm.70021","DOI":"10.1002\/cm.70021"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Firat-Karalar EN, Sante J, Elliott S, Stearns T. Proteomic analysis of mammalian sperm cells identifies new components of the centrosome. Journal of Cell Science. 2014; 127: 4128\u20134133.","DOI":"10.1242\/jcs.157008"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Zhang JZ, Wu ZH, Cheng Q. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis. Medicine. 2019; 98: e17997.","DOI":"10.1097\/MD.0000000000017997"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Ren J, Yang Y, Li C, Xie L, Hu R, Qin X, et al. A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers. Frontiers in Genetics. 2021; 11: 634634.","DOI":"10.3389\/fgene.2020.634634"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL54580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:22:45Z","timestamp":1790698965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL54580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02260-4"],"URL":"https:\/\/doi.org\/10.31083\/fbl54580","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"54580"}}